FDA 483 - OMID Holdings Inc. - October 15, 2025

An FDA inspection of OMID Holdings Inc., a dietary supplement manufacturer in Alpha, NJ, revealed significant deficiencies in their manufacturing and quality control processes. The firm failed to establish necessary specifications for components and finished products, maintain adequate master and batch production records, and ensure proper calibration of equipment. Additionally, personnel lacked formal training in current good manufacturing practices for dietary supplements.